Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2025 ,inter alia, to consider and approve the proposal for alteration in the share capital by sub-division / split of existing equity shares of the Company.
Titan Biotech Limited Press Release Nov 25 2025
Filed with BSE · · 1 page · English
Release
Story so far
Earlier from Titan Biotech
- Closure of Trading Window
- Titan Biotech Limited Press Release Nov 12 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Nov 11 2025
- Consolidated And Standalone Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
Later from Titan Biotech
- Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th November, 2025
- Corporate Action-Intimation of Sub division / Stock Split
- Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Titan Biotech Limited Press Release Nov 29 2025
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech